MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients

Affiliations

• ¹ Icahn School of Medicine at Mount Sinai, United States.
• ² Icahn School of Medicine at Mount Sinai, New York, New York, United States.
• ³ Univeristy of California, San Francisco, San Francisco, California, United States.
• ⁴ 1. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
• ⁵ Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai, New York, New York, United States.
• ⁶ Icahn School of Medicine at Mount Sinai, NEW YORK, New York, United States.
• ⁷ Mt. Sinai Medical Center, New York, New York, United States.